Printed From:

No statistically significant differences between Lantus® and standard care in the incidence of CV events in the landmark ORIGIN trial1-3

 

 

Hypoglycemia safety results1

 

aSevere hypoglycemia was defined as the need for assistance from another individual due to symptoms or signs of hypoglycemia and either prompt recovery with glucose or glucagon or a documented capillary glucose <2.0 mmol/L (36 mg/dL).3

 
 

 
 

CV safety and A1C reductions

View the data on CV safety and A1C reductions

 
References
  1. Lantus® Prescribing Information. August 2015.
  2. ORIGIN Trial Investigators. N Engl J Med. 2012;367(4):319-328.
  3. ORIGIN Trial Investigators. Am Heart J. 2008;155(1):26-32.